C-(8-METHYL-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)-METHYLAMINE HCL, 95.0%, 1g

4-Hydroxy-3,6,6-trimethyl-4,5,6,7-tetrahydro-benzofuran-2-carboxylic acid, 95.0%, 500mg

1,2,3-Benzotriazole, min 99%, pour la synthèse, 500 g, emballage plastique.

1-(3-METHYLPYRIDIN-4-YL)ETHANONE, 97.0%, 100mg

LM 22A4, 98.0%, 250mg

2-(TERT-BUTYL)ISOTHIAZOL-3(2H)-ONE, 95.0%, 500mg

1-Butyl-1-methylpyrrolidinium Bis(trifluoromethanesulfonyl)imide>98.0%(T)25g

1-Methyl-1,2,3,4-tetrahydroquinoline-5-carbaldehyde, 98%, 250mg

(4-((4-methoxyphenyl)carbamoyl)phenyl)boronic acid, 95+%, 250mg

4-Amino-1-cyclopropyl-2-pyrrolidinone hydrochloride, 95.0%, 250mg

2-(Difluoromethyl)benzimidazole>98.0%(GC)(T)1g

Ethyl 7-amino-2-(methoxymethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate, 95%, 1g

Piperidine-1-sulfonamide, 98%, 10g